SRSF3 and metabolic dysfunction-associated steatotic liver disease: The SRSF3 targets, however, only represented a small fraction of the total changes in splicing so other splicing factors might be involved and, indeed, we found that many RNA-binding proteins showed altered splicing in the NAFLD and NASH samples suggesting multifactorial dysregulation of RNA splicing.